Cargando…
Pharmacokinetic and Pharmacogenetic Predictors of Major Bleeding Events in Patients with an Acute Coronary Syndrome and Atrial Fibrillation Receiving Combined Antithrombotic Therapy
Objective: This study’s objective was to evaluate the effects of pharmacokinetic and pharmacogenetic factors on major bleeding in patients with ACS and non-valvular AF receiving combined antithrombotic therapy consisting of rivaroxaban, clopidogrel, and aspirin as part of dual or triple therapy. Met...
Autores principales: | Baturina, Olga, Chashkina, Maria, Andreev, Denis, Mirzaev, Karin, Bykova, Alexandra, Suvorov, Alexandr, Yeryshova, Daria, Suchkova, Svetlana, Sychev, Dmitry, Syrkin, Abram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532904/ https://www.ncbi.nlm.nih.gov/pubmed/37763139 http://dx.doi.org/10.3390/jpm13091371 |
Ejemplares similares
-
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban
por: Sychev, DA, et al.
Publicado: (2020) -
Evaluation of discriminative capacity of two formulas of CKD-EPI to predict complications after the first episode of heart failure with preserved ejection fraction
por: Shchekochikhin, Dmitry, et al.
Publicado: (2019) -
An algorithmic approach to gastrointestinal bleeding in patients receiving antithrombotic agents
por: Sadeghi, Amir, et al.
Publicado: (2020) -
Impact of laparoscopic liver resection on bleeding complications in patients receiving antithrombotics
por: Fujikawa, Takahisa, et al.
Publicado: (2017) -
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis
por: Kessler, Chiara, et al.
Publicado: (2020)